Pediatric Emergency Department Utilization and Coronavirus Disease in Daegu, Korea

Kyung Mi Jang1, Ji Young Ahn1, Hee Joung Choi2

  • 1Department of Pediatrics, Yeungnam University School of Medicine, Yeungnam University Hospital, Daegu, Korea.

Insights

The coronavirus disease 2019 (COVID-19) pandemic significantly reduced emergency department (ED) visits for children. This decrease impacted resource allocation and led to more severe conditions among those who did visit the ED.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Disease Epidemiology
  • Public Health

Background:

  • Limited data exist on pediatric emergency department (ED) utilization during the COVID-19 pandemic.
  • Understanding these trends is crucial for managing healthcare resources during outbreaks.

Purpose of the Study:

  • To examine emergency department (ED) utilization among pediatric patients during the COVID-19 pandemic.
  • To assess the impact of COVID-19 on pediatric ED visits in a major city.

Main Methods:

  • Retrospective study analyzing data from six EDs in Daegu, Korea.
  • Comparison of patient demographics and clinical data from February 1st-June 30th, 2020, with the same period in 2018-2019.

Main Results:

  • Pediatric ED visits decreased by 76.9% during the COVID-19 pandemic compared to previous years.
  • While overall visits increased from March 2020, pediatric visits remained below half of pre-pandemic levels by June 2020.
  • A higher proportion of adult and pediatric patients presented with severe conditions, leading to increased ambulance use and hospitalizations.

Conclusions:

  • The COVID-19 pandemic caused a substantial decline in pediatric ED utilization.
  • Findings can inform resource reallocation strategies for EDs during infectious disease outbreaks.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
766